Clinical Scenario

This protocol addresses patients with liver cirrhosis who have presented with a first episode of grade 2 (moderate) uncomplicated ascites and have not achieved an adequate response to first-line management.

Prior Line — Failure Condition

First-line therapy — moderate dietary sodium restriction combined with an anti-mineralocorticoid drug alone, escalated stepwise to maximum dose — did not achieve adequate body weight reduction. This inadequate response, or the development of hyperkalemia under that regimen, triggers escalation to the next treatment step.

Target not met: < 2 kg/week body weight reduction on first-line

Next Step — Treatment Approach

When anti-mineralocorticoid-based first-line therapy is insufficient, the protocol calls for adding a loop diuretic to the existing regimen in a structured escalation sequence. The complete dosing schedule, step sizes, and individualisation criteria are available in the full protocol.

Goal: ≥ 2 kg/week body weight reduction

References

DOI: 10.1016/j.jhep.2018.03.024

Patients with the first episode of grade 2 (moderate) ascites should receive an anti-mineralocorticoid drug alone, starting at 100 mg/day with stepwise increases every 72 h (in 100 mg steps) to a maximum of 400 mg/day if there is no response to lower doses (I;1).

In patients who do not respond to anti-mineralocorticoids, as defined by a body weight reduction of less than 2 kg/week, or in patients who develop hyperkalemia, furosemide should be added at an increasing stepwise dose from 40 mg/day to a maximum of 160 mg/day (in 40 mg steps) (I;1).

During diuretic therapy a maximum weight loss of 0.5 kg/day in patients without oedema and 1 kg/day in patients with oedema is recommended (II-2;1).

View source ↗

Grade 2 Moderate Ascites in Liver Cirrhosis: What to Do When Initial Diuretic Treatment Falls Short

References